BS
Bhushan Singh Rana
About Bhushan Singh Rana
Data last updated:
Bhushan Singh Rana is a Whole-Time Director at Brooks Laboratories Limited (since 2023) and Director at Abridge Speciality Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Brooks Laboratories Limited at ₹83.44 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brooks Laboratories Limited L24232HP2002PLC000267 | Whole-Time Director | 23 Aug 2023 | 2002 | ₹83.44 Cr (FY 2025) | Active |
 Abridge Speciality Limited U21001HP2026PLC012813 | Director | 02 Jul 2026 | 2026 | Active |
Board colleagues of Bhushan Singh Rana
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhushan Singh Rana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhushan Singh Rana
Bhushan Singh Rana currently holds 2 directorships: Brooks Laboratories Limited (Whole-Time Director, since 23 Aug 2023, revenue ₹83.44 Cr (FY 2025)); Abridge Speciality Limited (Director, since 02 Jul 2026).
Bhushan Singh Rana was first appointed on 23 Aug 2023 as Whole-Time Director at Brooks Laboratories Limited. The most recent appointment on record is 02 Jul 2026 at Abridge Speciality Limited.
The current boards of Bhushan Singh Rana's companies include Durga Shankar Maity (Brooks Laboratories Limited), Jitendrapratap Rambahadur Singh (Brooks Laboratories Limited), Krutika Mohan Rane (Brooks Laboratories Limited), Lalit Mahajan (Brooks Laboratories Limited), Manav Mahajan (Brooks Laboratories Limited), Prashant Rathi (Brooks Laboratories Limited), among others.